Multiple inflammatory markers, such as tumor necrosis factor α (TNF-α), interleukin-6 (IL-6), and vascular endothelial growth factor (VEGF) have demonstrated prognostic value in patients with colon cancer [9, 10]. The gene discussed is IL6; the disease is malignant colon neoplasm.